FSD3471 Medication Management Skills of Nursing Students in Finland and the Baltic Countries 2018-2019

Select variable


[fsd_no] FSD study number

[fsd_vr] FSD edition number

[fsd_id] FSD case id

[qnr] Questionnaire (added at FSD)

[q1] Age (years) (categorised at FSD)

[q3] Country

[q4] Phase of education

[q5] Number of clinical practice periods completed

[q6_1] Work experience in health care before entering the undergraduate nursing programme: nurse assistant (years, months)

[q6_1_1] Work experience in health care before entering the undergraduate nursing programme: nurse assistant (years, months) (categorised at FSD)

[q6_2] Work experience in health care before entering the undergraduate nursing programme: practical nurse (years, months)

[q6_2_1] Work experience in health care before entering the undergraduate nursing programme: practical nurse (years, months) (categorised at FSD)

[q6_3] Work experience in health care before entering the undergraduate nursing programme: no previous experience

[q6_4_lt] Work experience in health care before entering the undergraduate nursing programme: other healthcare professional (e.g. paramedic, pharmacist, etc.) (only in Lithuanian questionnaire)

[q7] Currently working as

[q8] Grades in examination on theoretical basis of pharmacotherapy (incl. principles of pharmacology, medication administration)

[q9] Have you passed the medication calculation exam?

[q10_1] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I am satisfied with the amount of education related to medication management at the university

[q10_2] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I am motivated to study topics related to medication management

[q10_3] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have actively participated in studies related to medication management at the university

[q10_4] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have actively studied medication management during clinical practice

[q10_5] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have actively maintained my medication competence

[q10_6] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have been active in using the eMedication Passport

[q10_7] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have actively practised medication calculations during clinical practice

[q10_8] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have confidence in my medication calculation skills

[q10_9] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have confidence in my medication administration skills

[q10_10] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have confidence in my decision-making skills in medication management

[q10_11] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have confidence to take the nurse's role in medication management

[q10_12] In the next items, we ask your perceptions of the studies related to medication management on a scale of 1 to 5: I have self-confidence to represent nurses in the multidisciplinary team responsible of patients medication care

[q11_1] In the next items, we ask your perception of learning medication management in the clinical practice. I have been introduced to the responsibilities and tasks on medication management in the beginning of the clinical practice

[q11_2] In the next items, we ask your perception of learning medication management in the clinical practice. I have had enough possibilities to practise medication management in clinical practice

[q11_3] In the next items, we ask your perception of learning medication management in the clinical practice. I have been able to apply my knowledge on medication care during clinical practice

[q11_4] In the next items, we ask your perception of learning medication management in the clinical practice. I have been expected to have better medication competence than I actually have

[q11_5] In the next items, we ask your perception of learning medication management in the clinical practice. I have performed too many tasks in medication care without adequate supervision

[q11_6] In the next items, we ask your perception of learning medication management in the clinical practice. I am satisfied with the supervision I have received when delivering tasks on medication care

[q11_7] In the next items, we ask your perception of learning medication management in the clinical practice. Nurse mentors have had an important role in how I have learned medication care

[q11_8] In the next items, we ask your perception of learning medication management in the clinical practice. A good supervision relationship with the mentor has enhanced my learning of medication care during the clinical practice

[q11_9] In the next items, we ask your perception of learning medication management in the clinical practice. Nurse mentors have had a positive attitude towards my supervision in medication care

[q11_10] In the next items, we ask your perception of learning medication management in the clinical practice. I have received feedback from nurse mentors on my medication competence development

[q11_11] In the next items, we ask your perception of learning medication management in the clinical practice. The nurse teachers supervising the clinical practice have supported me in setting personal learning goals in medication care

[q11_12] In the next items, we ask your perception of learning medication management in the clinical practice. The nurse teachers supervising the clinical practice have supported me in integrating theory and practise in medication care

[q11_13] In the next items, we ask your perception of learning medication management in the clinical practice. The medication education at the school and the medication care in clinical practice have corresponded well

[q11_14] In the next items, we ask your perception of learning medication management in the clinical practice. The use of eMedication Passport has supported my learning of medication care in clinical practice

[q12_1] Generic medicine

[q12_2_fi] The government authority responsible of supervising pharmacotherapy is (only in Finnish questionnaire)

[q12_2_et] The government authority responsible of supervising pharmacotherapy is (only in Estonian questionnaire)

[q12_2_lv] The government authority responsible of supervising pharmacotherapy is (only in Latvian questionnaire)

[q12_2_lt] The government authority responsible of supervising pharmacotherapy is (only in Lithuanian questionnaire)

[q12_3] Based on the legislation, a registered nurse is allowed to

[q12_4] In the medicine package, you find abbreviations i.v, i.o and i.t. What administration route you can use?

[q12_5] Generic drug substitute must have (only in Finnish and Lithuanian questionnaires)

[q12_6] Drug tolerance means

[q12_7] Pharmacokinetic medicine interaction means

[q12_8] A drug that is an agonist

[q12_9] The primary site of absorption of a drug is

[q12_10] The rate of absorption is the fastest from a drug

[q12_11] The score line in a tablet means that

[q12_12] An infusion concentrate

[q12_13] The effect of the drug begins fastest

[q12_14] The Z track technique in intramuscular injections

[q12_15] Enterotablets

[q12_16] A doctor has prescribed diclofenac 60 mg i.m. for your patient for pain. The strength of the medicine is 25 mg/ml. How many millilitres will you give to the patient?

[q12_17] A doctor has prescribed your patient to receive buprenorphine 400 micrograms every 6 hours. You have 0.2 mg/sublingual tablets at the ward. How many sublingual tablets does the patient need in a day?

[q12_18] Your patient is being administered continuous infusion for pain, containing 50 mg of morphine in 100 ml of Saline 0.9% with drop rate of 4.0 ml/h. How many milligrams of morphine did the patient receive from 6 a.m. to 1 p.m.?

[q12_19] A doctor has prescribed your patient 1000 ml of Saline 0.9% in 8 hours. What is the accurate drop rate of the infusion?

[q12_20] The strength of the mouth wash concentrate for mouth ulcers is 0.2%. The instruction is to take 5 ml of the concentrate and dilute it with 5 ml of sterile Aqua. How strong (%) is the dilution you prepared?

[q12_21] The patient has fallen at home. He has symptoms of intracerebral haemorrhage, such as confusion, headache, nausea and anxiety. Which of the following infusion fluids should be avoided or administered with caution?

[q12_22] You have an elderly patient at home care. She has chronic atrial fibrillation and has warfarin for prevention of embolism. What is the optimal goal for INR-level in most patients with chronic atrial fibrillation?

[q12_23] Your patient has hepatic insufficiency. He has some lower back pains. However, now he needs your advice on what to take for the pain. Which of the following pain medication should be avoided with hepatic insufficiency patients?

[q12_24] You have an 84-year-old patient with coronary artery disease and cardiac insufficiency. He has forgotten to take his long-acting nitrate and diuretic medicine in the morning. What would you advise him to do with the medication?

[q12_25] Your patient asks your advice on her antimicrobial regimen. She will be attending a friend's party and she is having metronidazole antimicrobial drug for an infection. Which of the following would be correct with this medication?

[q12_26] The abbreviation s.c. stands for (only in Estonian and Latvian questionnaires)

[q13] I participated in the pilot study (only in Estonian, Latvian and Lithuanian questionnaires)

Study description in machine readable DDI-C 2.5 format

Creative Commons License
Metadata record is licensed under a Creative Commons Attribution 4.0 International license.